Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA Mounjaro headache most often feels like a dull, pressure-type ache across the forehead or temples, similar to a tension headache. It tends to arrive in the first day or two after an injection and usually settles within 24 to 48 hours. Headaches are listed among the common side effects of tirzepatide in the NHS medicines information for tirzepatide, and most people who experience them find they ease as the body adjusts to treatment. These are prescription-only medicines, so a GPhC-registered prescriber reviews your full picture before any treatment starts — headache patterns, their frequency, and whether anything else is going on all factor into that assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tension-type is the most common description. A tightness or heaviness around the front of the head, sometimes spreading to the temples or the base of the skull. It rarely throbs the way a migraine does, and most people rate it as mild to moderate rather than severe. Some notice it most on injection day or the morning after; others find it peaks a day or so later as tirzepatide's activity ramps up. The pattern tends to mirror the medicine's weekly rhythm, more noticeable in the first few weeks of treatment or after a dose step up, then gradually less frequent as the body settles.
Dehydration is a frequent co-conspirator. Tirzepatide slows gastric emptying and often reduces appetite significantly, which can mean eating and drinking less without realising it. If nausea is also present, fluid intake can drop further. A headache that arrives a few hours after injection and responds reasonably well to water and paracetamol is often more about hydration than the medicine itself. Our Mounjaro side effects overview covers the wider GI picture and why it matters for how you feel day to day.
Location and character matter when you're deciding what to do next. A familiar tension headache that responds to simple analgesia and resolves within 48 hours sits in a very different category from a sudden, severe headache unlike anything before, or one accompanied by visual changes, confusion, or neck stiffness. The latter needs urgent medical attention, full stop.
When a headache appears after a Mounjaro injection, most people face the same quiet calculation: is this the medicine, something else, or something I should worry about? The honest answer is that it's usually the medicine, but that probability doesn't replace assessment. A few factors sharpen the picture.
Timing is the first. A headache arriving within 24 hours of the injection, particularly in the early weeks, fits the known side-effect profile well. One that appears days later with no other symptoms may have an unrelated cause entirely. Headaches that come after a Mounjaro injection follow a recognisable pattern that's worth understanding before your first pen, not after.
Severity and character are the second factor. Mild to moderate, familiar in texture, and responsive to standard over-the-counter remedies sits firmly in the manageable camp. A headache that gets worse instead of better, that you'd describe as the worst of your life, or that comes with fever, sensitivity to light, or a stiff neck does not. Those symptoms warrant calling 111 or going to A&E, not a pharmacist's chat, and certainly not waiting until next week's injection.
Frequency over weeks is the third. One or two headaches in the first month of treatment is common. Headaches every week, reliably tied to injection day, week after week, is worth discussing with your prescriber. Dose timing, hydration strategy, and whether to review the titration schedule are all levers a prescriber can pull. Our page on why Mounjaro causes headaches goes into the physiology in more detail, which can help that conversation.
The NHS medicines information for tirzepatide lists headache as a common side effect, meaning it affects somewhere between one in ten and one in a hundred users. That framing is reassuring, but it doesn't mean every headache on Mounjaro is benign by definition.
Seek urgent medical help if you experience: a sudden, severe headache that came on in seconds (a so-called thunderclap headache); headache with visual disturbance, confusion, or weakness on one side of the body; headache alongside fever and neck stiffness; or headache that keeps worsening despite analgesia over several hours. None of these presentations should be attributed to Mounjaro without a clinician ruling out other causes first. Call 999 for the most severe or sudden onset; 111 for urgent but not emergency situations.
The MHRA's Yellow Card reporting scheme exists so that patients and carers can report suspected side effects directly to the regulator. If you experience headaches or any other effect you think may be related to tirzepatide, reporting it contributes to the ongoing safety monitoring that all medicines with Black Triangle status (▼) receive. Mounjaro carries that status.
For a fuller look at how long this particular side effect typically lasts, the page on how long a Mounjaro headache lasts covers the duration data in plain terms. And if diarrhoea is also part of the picture (which affects hydration and therefore headache risk) persistent diarrhoea on Mounjaro is worth reading alongside this one.
Drink water first. It sounds basic, but even mild dehydration measurably worsens headache intensity, and tirzepatide users often underestimate how much their fluid intake has dropped. Aim for consistent sips throughout the day rather than large amounts all at once, especially if nausea is also present.
Standard paracetamol, taken at the recommended dose, is appropriate for mild to moderate headache. Ibuprofen is an option for some people but check with your pharmacist if you have any stomach sensitivity, GI side effects and NSAIDs together are worth thinking about. Don't exceed recommended doses or combine analgesics without advice.
Rest, a cool room, and reduced screen time all help the type of tension headache Mounjaro typically produces. If the headache is reliably appearing on injection day, some people find shifting the injection to the evening means the worst of it passes overnight. That's a practical adjustment worth raising at your next prescriber check-in rather than making unilaterally, particularly around dose changes.
If you're considering Mounjaro or want to understand more before starting, our prescribers cover side effects, including headache patterns, as part of every free consultation. Nothing about your history is too small to mention, that's exactly what the review is for. You can also read about the full Mounjaro treatment overview or explore weight-loss treatment options more broadly if you're still deciding which route suits you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.